Skip to main navigation Skip to search Skip to main content

Brodalumab for treating moderate to severe plaque psoriasis. Evidence Review Group Report for the National Institute for Health and Care Excellence

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health Research (NIHR)
Publication statusPublished - 2017

Cite this